Losartan for Preventing Aortic Root Dilatation in Patients with Marfan Syndrome: A Meta-Analysis of Randomized Trials

Ayman Elbadawi, Mohamed A. Omer, Islam Y. Elgendy, Ahmed Abuzaid, Ahmed H. Mohamed, Devesh Rai, Marwan Saad, Amgad Mentias, Ahmed Rezq, Diaa Kamal, Wissam Khalife, Barry London, Mohamed Morsy

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Introduction: The role of losartan in preventing aortic root dilatation in Marfan syndrome has been evaluated in many clinical trials; however, the results are conflicting. Methods: We performed a computerized search of MEDLINE, EMBASE and COCHRANE databases through February 2019 for randomized clinical trials evaluating the effect of losartan in patients with Marfan syndrome. The main outcome was the change in the aortic root diameter in the losartan versus control groups. Results: Our final analysis included seven randomized trials with a total of 1352 patients and average weighted follow-up of 37.8 months. Change in aortic root diameter was significantly smaller with losartan compared with control [weighted means: 0.44 vs. 0.58 mm, mean difference (MD) = −0.13; 95% CI −0.24 to −0.02; p = 0.02]. Subgroup analysis according to the control group showed no significant subgroup interaction when comparing losartan with beta-blockers versus with standard therapy (pinteraction= 0.27). The composite outcome of aortic surgery, dissection or mortality did not differ between the losartan and control groups (risk ratio = 1.03; 95% CI 0.72–1.49, p = 0.86). Conclusion: In this meta-analysis including seven randomized trials, the use of losartan was associated with a significantly smaller change in aortic root diameter in patients with Marfan syndrome.

Original languageEnglish (US)
Pages (from-to)365-372
Number of pages8
JournalCardiology and Therapy
Issue number2
StatePublished - Dec 1 2019


  • Angiotensin receptor blocker
  • Aortic dilatation
  • Beta-blocker
  • Losartan
  • Marfan syndrome

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Losartan for Preventing Aortic Root Dilatation in Patients with Marfan Syndrome: A Meta-Analysis of Randomized Trials'. Together they form a unique fingerprint.

Cite this